SS Innovations Sets Milestone with Groundbreaking Telesurgery
SS Innovations Achieves a Historic Milestone in Robotic Surgery
In a remarkable advancement for the field of robotic surgery, SS Innovations International, Inc. (Nasdaq: SSII) has announced the successful completion of the world’s first intercontinental robotic cardiac telesurgery. This innovative procedure was performed by Dr. Sudhir Srivastava, the Company’s Chairman and CEO, using their cutting-edge SSi Mantra 3 surgical robotic system.
A Groundbreaking Cardiac Surgery
The groundbreaking surgery took place during the Society of Robotic Surgery Annual Meeting in Strasbourg, France, and it was conducted remotely from a distance exceeding 4,000 miles to the Sri Aurobindo Institute of Medical Sciences in Indore, India. Dr. Srivastava’s patient underwent a complex cardiac procedure known as robotic atrial septal defect closure. This procedure is particularly important, as it addresses critical heart conditions that can significantly impact a patient's quality of life.
Collaboration Across Continents
Support on the patient’s side was expertly coordinated by a skilled team of medical professionals from various hospitals. Notable contributors included Dr. Lalit Malik, Chief of Cardiac Surgery; Dr. Ram Krishna Shukla, Cardiologist; and Dr. Bipin Arya, Anesthesiologist. Their collaboration ensured a seamless surgery experience, highlighting the importance of teamwork in modern medicine.
Flawless Execution and Advanced Technology
The surgery was performed using the advanced features of the SSi Mantra 3, including real-time imaging and robotic control, which ensured precision and minimized latency. Surgical moderator Dr. Husam H. Balkhy, a renowned robotic cardiac surgeon, praised the flawless execution of the procedure and the technology’s capabilities.
Redefining Access to Cardiac Care
Dr. Srivastava emphasized the importance of this achievement for global healthcare, expressing gratitude to the collaborative efforts that made this historic telesurgery a reality. He stated, “This achievement showcases the advanced capabilities of our SSi Mantra 3 surgical robotic system and paves the way for improving accessibility to complex cardiac care in regions that traditionally face surgical expertise challenges.”
SS Innovations' Vision
SS Innovations is committed to expanding access to robotic surgery worldwide. With their SSi Mantra platform, they aim to break down barriers related to travel, costs, and surgical availability. By streamlining procedures and enhancing robotic technology, the Company envisions creating a more efficient and equitable system in healthcare.
Proven Track Record in Surgical Innovation
To date, the SSi Mantra system has been utilized in 35 telesurgeries, including ten cardiac procedures, contributing to a collective total of 250 cardiac surgeries. The system is recognized for its reliability, having successfully completed over 5,000 multi-specialty surgeries without any reported adverse events related to the device.
Regulatory Approval
Importantly, SS Innovations stands out as the only surgical robotic company to have received regulatory approval from India’s Central Drugs Standard Control Organization (CDSCO) for both teleproctoring and telesurgery, further establishing its innovative position in the market.
About SS Innovations
Founded to make robotic surgery more affordable and accessible, SS Innovations International, Inc. develops groundbreaking surgical robotic technologies. Their flagship product, the SSi Mantra system, is complemented by a suite of advanced surgical instruments designed for various medical specialties. The Company aims to expand its presence globally, offering innovative and cost-effective surgical solutions.
Frequently Asked Questions
What type of procedure was performed during the telesurgery?
The procedure conducted was a robotic atrial septal defect closure.
Who were the notable medical professionals involved in the surgery?
Dr. Lalit Malik, Dr. Ram Krishna Shukla, and Dr. Bipin Arya supported the procedure in Indore.
What technology was utilized in this telesurgery?
The SSi Mantra 3 surgical robotic system was employed for its advanced capabilities.
How many telesurgeries has SS Innovations accomplished?
SS Innovations has successfully completed 35 telesurgeries to date.
What makes SS Innovations unique in the surgical robotics industry?
It is the only company to receive regulatory approval for both teleproctoring and telesurgery from CDSCO in India.
About The Author
Contact Ryan Hughes privately here. Or send an email with ATTN: Ryan Hughes as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.